GeoVax Labs, Inc. Operating Income Loss

• GeoVax Labs, Inc. showed an increase of +6.0% in Operating Income Loss from 2023 to 2024.
• This data is from GeoVax Labs, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
• XBRL data for this metric is available from 2009 to 2024 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2009 to 2024), GeoVax Labs, Inc.'s Operating Income Loss has declined by 658.4%.
• Historical annual values: Fiscal year 2024: -$25.14 million | Fiscal year 2023: -$26.74 million | Fiscal year 2022: -$14.03 million | Fiscal year 2021: -$18.75 million | Fiscal year 2020: -$2.82 million | Fiscal year 2019: -$2.37 million | Fiscal year 2018: -$2.56 million | Fiscal year 2017: -$2.17 million | Fiscal year 2016: -$3.27 million | Fiscal year 2015: -$2.69 million | Fiscal year 2014: -$2.74 million | Fiscal year 2013: -$2.29 million | Fiscal year 2012: -$2.14 million | Fiscal year 2011: -$2.35 million | Fiscal year 2010: -$2.77 million | Fiscal year 2009: -$3.32 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026